Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$16.4 million.
- Treace Medical Concepts' Income from Continuing Operations fell 650.2% to -$16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.6 million, marking a year-over-year increase of 1820.3%. This contributed to the annual value of -$56.1 million for FY2024, which is 1242.86% down from last year.
- Per Treace Medical Concepts' latest filing, its Income from Continuing Operations stood at -$16.4 million for Q3 2025, which was down 650.2% from -$17.5 million recorded in Q2 2025.
- In the past 5 years, Treace Medical Concepts' Income from Continuing Operations ranged from a high of -$619000.0 in Q4 2024 and a low of -$21.3 million during Q2 2024
- Over the past 5 years, Treace Medical Concepts' median Income from Continuing Operations value was -$12.4 million (recorded in 2023), while the average stood at -$11.3 million.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first plummeted by 35788.86% in 2021, then surged by 9029.32% in 2024.
- Quarter analysis of 5 years shows Treace Medical Concepts' Income from Continuing Operations stood at -$6.6 million in 2021, then skyrocketed by 38.75% to -$4.1 million in 2022, then plummeted by 57.26% to -$6.4 million in 2023, then skyrocketed by 90.29% to -$619000.0 in 2024, then crashed by 2546.2% to -$16.4 million in 2025.
- Its Income from Continuing Operations was -$16.4 million in Q3 2025, compared to -$17.5 million in Q2 2025 and -$16.1 million in Q1 2025.